Richard D. Press

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A novel activating JAK1 mutation in chronic eosinophilic leukemia”.

A novel activating JAK1 mutation in chronic eosinophilic leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004237

N/A

0DataRank · unranked

21 citations

Alisa Damnernsawad, Talent Theparee, David A. Sampson, Quinlan Morrow, Fei Yang +6 more

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Blood Advances(2021)10.1182/bloodadvances.2021004983

N/A

0DataRank · unranked

6 citations

Matthew M. Klairmont, Joel F. Gradowski, Kohei Hagiwara, Nathanael G. Bailey, Pranil Chandra +11 more

Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy

Cancer Cell(2024)10.1016/j.ccell.2024.08.004

N/A

0DataRank · unranked

15 citations

Diana Brewer, Tao Xie, Anna Reister Schultz, Samantha L. Savage, Serena Muratcioğlu +11 more

Impact of Germline CHEK2 Pathogenic Variants on the Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome

Cancer Epidemiology Biomarkers & Prevention(2025)10.1158/1055-9965.epi-25-1074

N/A

0DataRank · unranked

1 citations

Nicola Long, Jonathan C. Savage, Jose M. Solis-Ruiz, Y. Li, Angela C. Holt +7 more